Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-14
DOI
10.1038/s41574-020-0341-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The prevention of glucocorticoid-induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper
- (2019) Quentin A. Hill et al. BRITISH JOURNAL OF HAEMATOLOGY
- Denosumab vs risedronate in glucocorticoid-induced osteoporosis: final results of a 24-month randomized, double-blind, double-dummy trial
- (2019) Kenneth G. Saag et al. Arthritis & Rheumatology
- Glucocorticoid-induced osteoporosis: 2019 concise clinical review
- (2019) G. Adami et al. OSTEOPOROSIS INTERNATIONAL
- Effect of Zoledronate on Bone Loss After Romosozumab/Denosumab: 2-Year Follow-up
- (2019) Anne M. Horne et al. CALCIFIED TISSUE INTERNATIONAL
- Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2‐year Clinical Trial
- (2019) Athanasios D. Anastasilakis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Tanshinol alleviates impaired bone formation by inhibiting adipogenesis via KLF15/PPARγ2 signaling in GIO rats
- (2018) Ya-jun Yang et al. ACTA PHARMACOLOGICA SINICA
- WNT16 overexpression partly protects against glucocorticoid-induced bone loss
- (2018) Claes Ohlsson et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease
- (2018) Olorunfemi A. Oshagbemi et al. BONE
- Autophagy as a target for glucocorticoid-induced osteoporosis therapy
- (2018) Gengyang Shen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Glucocorticoids inhibit notch target gene expression in osteoblasts
- (2018) Stefano Zanotti et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway
- (2018) M. Hoff et al. OSTEOPOROSIS INTERNATIONAL
- Therapeutic Mechanisms of Glucocorticoids
- (2018) Jolien Vandewalle et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
- (2018) Susanne Hildebrandt et al. Scientific Reports
- Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
- (2018) Kenneth G Saag et al. Lancet Diabetes & Endocrinology
- Osteoblast autophagy in glucocorticoid-induced osteoporosis
- (2018) Lufei Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone
- (2017) Kristian F. Axelsson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inhaled glucocorticoids are associated with vertebral fractures in COPD patients
- (2017) Pedro Assed Gonçalves et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
- (2017) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
- (2017) Athanasios D Anastasilakis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ
- (2017) Aliya A. Khan et al. JOURNAL OF CLINICAL DENSITOMETRY
- Prevention and management of glucocorticoid-induced side effects: A comprehensive review
- (2017) Avrom Caplan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Beyond bone mineral density, FRAX-based tailor-made intervention thresholds for therapeutic decision in subjects on glucocorticoid
- (2017) Shan-Fu Yu et al. MEDICINE
- Observations following discontinuation of long-term denosumab therapy
- (2017) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- The Incidence of Atypical Femoral Fractures in Patients with Rheumatic Disease: Yamagata Prefectural Committee of Atypical Femoral Fractures (YamaCAFe) Study
- (2017) Yuya Takakubo et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
- (2017) Lenore Buckley et al. ARTHRITIS CARE & RESEARCH
- UK clinical guideline for the prevention and treatment of osteoporosis
- (2017) J. Compston et al. Archives of Osteoporosis
- Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids
- (2017) Luca Parente BMC Pharmacology & Toxicology
- Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice
- (2016) Marilina Piemontese et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Notch Signaling and the Skeleton
- (2016) Stefano Zanotti et al. ENDOCRINE REVIEWS
- Bisphosphonate-related osteonecrosis of the jaw: data from the French national pharmacovigilance database
- (2016) Paul de Boissieu et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis
- (2016) Paul D. Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis
- (2016) A. Balasubramanian et al. OSTEOPOROSIS INTERNATIONAL
- The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2016) Rachel J. Black et al. PLoS One
- Multiple clinical vertebral fractures following denosumab discontinuation
- (2015) A. D. Anastasilakis et al. OSTEOPOROSIS INTERNATIONAL
- Rebound-associated vertebral fractures after discontinuation of denosumab—from clinic and biomechanics
- (2015) A. W. Popp et al. OSTEOPOROSIS INTERNATIONAL
- Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials
- (2015) M. A. Amiche et al. OSTEOPOROSIS INTERNATIONAL
- Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis
- (2015) Dae Hyun Kim et al. PLoS One
- Adverse Consequences of Glucocorticoid Medication: Psychological, Cognitive, and Behavioral Effects
- (2014) Lewis L. Judd et al. AMERICAN JOURNAL OF PSYCHIATRY
- Impact of Femoral Neck and Lumbar Spine BMD Discordances on FRAX Probabilities in Women: A Meta-analysis of International Cohorts
- (2014) H. Johansson et al. CALCIFIED TISSUE INTERNATIONAL
- 2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis
- (2014) Karine Briot et al. JOINT BONE SPINE
- The incidence of and risk factors for developing atypical femoral fractures in Japan
- (2014) Yoshitomo Saita et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update
- (2014) Yasuo Suzuki et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Glucocorticoid-induced osteoporosis in men
- (2014) R. A. Adler et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Glucocorticoid-induced osteoporosis: who to treat with what agent?
- (2014) René Rizzoli et al. Nature Reviews Rheumatology
- Risk of Serious Atrial Fibrillation and Stroke With Use of Bisphosphonates
- (2013) Abhishek Sharma et al. CHEST
- Targeting 11β-hydroxysteroid dehydrogenases: a novel approach to manipulating local glucocorticoid levels with implications for rheumatic disease
- (2013) Rowan S Hardy et al. CURRENT OPINION IN PHARMACOLOGY
- The Osteocyte: An Endocrine Cell … and More
- (2013) Sarah L. Dallas et al. ENDOCRINE REVIEWS
- Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial
- (2013) Claus-C Glüer et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Renal safety in patients treated with bisphosphonates for osteoporosis: A review
- (2013) Paul D Miller et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
- (2013) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Disconnect Between Better Quality of Glucocorticoid-induced Osteoporosis Preventive Care and Better Outcomes: A Population-based Cohort Study
- (2013) S. R. Majumdar et al. JOURNAL OF RHEUMATOLOGY
- Risk of Severe Upper Gastrointestinal Complications among Oral Bisphosphonate Users
- (2013) Arianna Ghirardi et al. PLoS One
- Osteoporosis in the European Union: medical management, epidemiology and economic burden
- (2013) E. Hernlund et al. Archives of Osteoporosis
- Management of Glucocorticoid-Induced Osteoporosis
- (2012) R. Rizzoli et al. CALCIFIED TISSUE INTERNATIONAL
- Severe hypercalcemia due to teriparatide
- (2012) Cumali Karatoprak et al. INDIAN JOURNAL OF PHARMACOLOGY
- Population-Based Trends in Osteoporosis Management after New Initiations of Long-Term Systemic Glucocorticoids (1998–2008)
- (2012) S. R. Majumdar et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment failure in osteoporosis
- (2012) A. Diez-Perez et al. OSTEOPOROSIS INTERNATIONAL
- A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
- (2012) S. Lekamwasam et al. OSTEOPOROSIS INTERNATIONAL
- Prevalence of oral glucocorticoid usage in the United States: A general population perspective
- (2012) Robert A. Overman et al. ARTHRITIS CARE & RESEARCH
- Physiological Notch Signaling Maintains Bone Homeostasis via RBPjk and Hey Upstream of NFATc1
- (2012) Xiaolin Tu et al. PLoS Genetics
- Diretrizes para prevenção e tratamento da osteoporose induzida por glicocorticoide
- (2012) Rosa Maria Rodrigues Pereira et al. Revista Brasileira De Reumatologia
- Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate
- (2011) Philip N. Sambrook et al. BONE
- International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine Position on bone marker standards in osteoporosis
- (2011) Samuel Vasikaran et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Clinical Question: What is the best approach to managing glucocorticoid-induced osteoporosis?
- (2011) Juliet Compston CLINICAL ENDOCRINOLOGY
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Risk of hip fracture in Addison’s disease: a population-based cohort study
- (2011) S. Björnsdottir et al. JOURNAL OF INTERNAL MEDICINE
- Glucocorticoid-Induced Bone Disease
- (2011) Robert S. Weinstein NEW ENGLAND JOURNAL OF MEDICINE
- Guidance for the adjustment of FRAX according to the dose of glucocorticoids
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years
- (2011) L. Fardet et al. RHEUMATOLOGY
- Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies
- (2011) Y. K. Loke et al. THORAX
- Advances in Glucocorticoid-Induced Osteoporosis
- (2011) Debby den Uyl et al. Current Rheumatology Reports
- Resolution of Oral Bisphosphonate and Steroid-Related Osteonecrosis of the Jaw—A Serial Case Analysis
- (2010) Chang-Ta Chiu et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Skeletal Diseases in Cushing’s Syndrome: Osteoporosis versus Arthropathy
- (2010) Gregory Kaltsas et al. NEUROENDOCRINOLOGY
- Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice
- (2009) Robert S. Weinstein et al. AGING CELL
- Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial
- (2009) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- Age Dependence of Early Symptomatic Vertebral Fracture with High-Dose Glucocorticoid Treatment for Collagen Vascular Diseases
- (2009) Ichiro Tatsuno et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Baseline Glucocorticoid Dose and Bone Mineral Density Response with Teriparatide or Alendronate Therapy in Patients with Glucocorticoid-induced Osteoporosis
- (2009) J.-P. DEVOGELAER et al. JOURNAL OF RHEUMATOLOGY
- Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2009) David M Reid et al. LANCET
- Minireview: Live and Let Die: Molecular Effects of Glucocorticoids on Bone Cells
- (2009) Lorenz C. Hofbauer et al. MOLECULAR ENDOCRINOLOGY
- Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: A longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice
- (2008) Wei Yao et al. ARTHRITIS AND RHEUMATISM
- Modulation of Dickkopf-1 Attenuates Glucocorticoid Induction of Osteoblast Apoptosis, Adipocytic Differentiation, and Bone Mass Loss
- (2008) Feng-Sheng Wang et al. ENDOCRINOLOGY
- Osteoporosis in Men
- (2008) Peter R. Ebeling NEW ENGLAND JOURNAL OF MEDICINE
- Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science
- (2008) J. Compston et al. OSTEOPOROSIS INTERNATIONAL
- Relationship between extracellular matrix, contractile apparatus, muscle mass and strength in case of glucocorticoid myopathy
- (2007) Eva-Maria Riso et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation